All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
08/16/99	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-27.1			23
07/29/99	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Related Documents EX-1 EX-2			66
07/27/99	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities			6
05/27/99	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Related Documents EX-5.1 EX-23.2 EX-99.1 EX-99.4			39
05/14/99	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-3.3 EX-10.3 EX-10.4 EX-27.1			69
04/16/99	DEF 14A	Definitive proxy statements			60
03/31/99	10-K	Annual report pursuant to Section 13 and 15(d) Related Documents EX-10.194 EX-10.195 EX-10.196 EX-21.1 EX-23.1 EX-27.1			156
02/09/99	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			6
01/06/99	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Related Documents EX-1 EX-2			69
12/30/98	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Related Documents EX-5.1 EX-23.2 EX-99.1 EX-99.2			52